The Crohn's & Colitis Foundation Appoints Chris Fidyk as Executive Vice President, Business Development
Published: September 24, 2024
Contact:
Rachel Peifer
[email protected]
NEW YORK, NY - September 24, 2024 - The Crohn's & Colitis Foundation, the leading non-profit organization focused on finding cures for Crohn's disease and ulcerative colitis, announced the appointment of Chris Fidyk as Executive Vice President, Business Development. In this role, Fidyk will lead the Foundation's business development initiatives, leveraging his extensive experience in healthcare and life sciences to drive innovative solutions for patients with inflammatory bowel disease (IBD).
Fidyk brings more than 20 years of experience in the healthcare and life sciences industries to the Foundation. He began his career in sales and marketing at Amgen. Following that, he spent nearly a decade at PatientsLikeMe (acquired by UnitedHealth Group) where he led business development. Most recently, Fidyk spearheaded commercialization efforts at several innovative health data and technology startups, four of which were acquired generating $1.1 billion in realized value to shareholders.
"Chris's proven track record in driving innovation and his passion for improving patient outcomes make him an ideal addition to our leadership team," said Michael Osso, President and CEO of the Crohn's & Colitis Foundation. "His expertise in forging strategic partnerships and commercializing healthcare solutions will be invaluable as we continue to accelerate research and enhance patient care for those living with IBD."
Fidyk holds a BS in computer science from Columbia University and an MBA in entrepreneurship from UCLA Anderson. He and his family reside in Boston, MA.
Crohn's & Colitis Foundation
The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of curing Crohn’s disease and ulcerative colitis and improving the quality of life for the millions of Americans living with IBD. The Foundation’s work is dramatically accelerating the research process, while also providing extensive educational and support resources for patients and their families, medical professionals, and the public.